Abstract

Mesenchymal stem cells (MSCs) are well known for their regenerative potential. Even though the ability of MSCs to proliferate and differentiate has been studied extensively, there remains much to learn about the signaling mechanisms and pathways that control proliferation and influence the differentiation phenotype. In recent years, there has been growing evidence for the utility of non-neuronal cholinergic signaling systems and that acetylcholine (ACh) plays an important ubiquitous role in cell-to-cell communication. Indeed, cholinergic signaling is hypothesized to occur in stem cells and ACh synthesis, as well as in ACh receptor (AChR) expression, has been identified in several stem cell populations, including MSCs. Furthermore, AChRs have been found to influence MSC regenerative potential. In humans, there are two major classes of AChRs, muscarinic AChRs and nicotinic AChRs, with each class possessing several subtypes or subunits. In this review, the expression and function of AChRs in different types of MSC are summarized with the aim of highlighting how AChRs play a pivotal role in regulating MSC regenerative function.

Get full access to this article

View all available purchase options and get full access to this article.

References

1. Wessler I and CJ Kirkpatrick. (2008). Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154:1558–1571.
2. Tracey KJ. (2007). Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289–296.
3. Arredondo J, AI Chernyavsky, DL Jolkovsky and KE Pinkerton. (2007). Receptor-mediated tobacco toxicity: alterations of the NF-κB expression and activity downstream of α7 nicotinic receptor in oral keratinocytes. Life Sci 80:2191–2194.
4. Arredondo J, AI Chernyavsky, LM Marubio, AL Beaudet, DL Jolkovsky, KE Pinkerton and SA Grando. (2005). Receptor-mediated tobacco toxicity: regulation of gene expression through α3β2 nicotinic receptor in oral epithelial cells. Am J Pathol 166:597–613.
5. Paraoanu LE, G Steinert, A Koehler, I Wessler and PG Layer. (2007). Expression and possible functions of the cholinergic system in a murine embryonic stem cell line. Life Sci 80:2375–2379.
6. Serobyan N, S Jagannathan, I Orlovskaya, I Schraufstatter, M Skok, J Loring and S Khaldoyanidi. (2007). The cholinergic system is involved in regulation of the development of the hematopoietic system. Life Sci 80:2352–2360.
7. Grassi F, F Pagani, G Spinelli, L De Angelis, G Cossu and F Eusebi. (2004). Fusion-independent expression of functional ACh receptors in mouse mesoangioblast stem cells contacting muscle cells. J Physiol 560:479–489.
8. Hoogduijn MJ, A Cheng and PG Genever. (2009). Functional nicotinic and muscarinic receptors on mesenchymal stem cells. Stem Cells Dev 18:103–112.
9. Piovesana R, S Melfi, M Fiore, V Magnaghi and AM Tata. (2018). M2 muscarinic receptor activation inhibits cell proliferation and migration of rat adipose-mesenchymal stem cells. J Cell Physiol 233:5348–5360.
10. Albuquerque EX, EFR Pereira, M Alkondon and SW Rogers. (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73–120.
11. Wessler I, CJ Kirkpatrick and K Racké. (1998). Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77:59–79.
12. Eglen RM. (2005). Muscarinic receptor subtype pharmacology and physiology. Prog Med Chem 43:105–136.
13. Forsgren S, H Alfredson, D Bjur, S Rantapää-Dahlqvist, Ö Norrgård, T Dalén and P Danielson. (2009). Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases. Orthop Rev (Pavia) 1:11.
14. Miyazawa A, Y Fujiyoshi and N Unwin. (2003). Structure and gating mechanism of the acetylcholine receptor pore. Nature 423:949.
15. Grando SA. (1997). Biological functions of keratinocyte cholinergic receptors. J Investig Dermatology Symp Proc 2:41–48.
16. Shirvan MH, HB Pollard and E Heldman. (1991). Mixed nicotinic and muscarinic features of cholinergic receptor coupled to secretion in bovine chromaffin cells. Proc Natl Acad Sci U S A 88:4860–4864.
17. Bencherif M and RJ Lukas. (1993). Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton. J Neurochem 61:852–864.
18. Evinger MJ, P Ernsberger, S Regunathan, TH Joh and DJ Reis. (1994). A single transmitter regulates gene expression through two separate mechanisms: cholinergic regulation of phenylethanolamine N-methyltransferase mRNA via nicotinic and muscarinic pathways. J Neurosci 14:2106–2116.
19. Eglen RM. (2006). Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol 26:219–233.
20. Maeda S, Q Qu, MJ Robertson, G Skiniotis and BK Kobilka. (2019). Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes. Science 364:552–557.
21. Eglen RM. (2012). Overview of muscarinic receptor subtypes. In: Muscarinic Recept. Berlin, Heidelberg: Springer, pp. 3–28.
22. Resende RR and A Adhikari. (2009). Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun Signal 7:20.
23. Leach K, J Simms, PM Sexton and A Christopoulos. (2012). Structure–function studies of muscarinic acetylcholine receptors. In: Muscarinic Recept. Berlin, Heidelberg: Springer, pp. 29–48.
24. Jacoby E, R Bouhelal, M Gerspacher and K Seuwen. (2006). The 7 TM G-protein-coupled receptor target family. ChemMedChem 1:760–782.
25. Sriram K and PA Insel. (2018). G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Mol Pharmacol 93:251–258.
26. Lappano R and M Maggiolini. (2011). G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 10:47–60.
27. Dani JA and D Bertrand. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699–729.
28. Weist R, T Flörkemeier, Y Roger, A Franke, K Schwanke, R Zweigerdt, U Martin, E Willbold and A Hoffmann. (2018). Differential expression of cholinergic system components in human induced pluripotent stem cells, bone marrow-derived multipotent stromal cells, and induced pluripotent stem cell-derived multipotent stromal cells. Stem Cells Dev 27:166–183.
29. Gahring LC and SW Rogers. (2005). Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J 7:E885–E894.
30. Thuong Nguyen V, LL Hall, G Gallacher, A Ndoye, DL Jolkovsky, RJ Webber, R Buchli and SA Grando. (2000). Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia. J Dent Res 79:939–949.
31. Dicker A, M Kaaman, V van Harmelen, G Åström, KL Blanc and M Ryden. (2005). Differential function of the α2A-adrenoceptor and phosphodiesterase-3B in human adipocytes of different origin. Int J Obes 29:1413–1421.
32. Friedenstein AJ, UF Deriglasova, NN Kulagina, AF Panasuk, SF Rudakowa, EA Luria and IA Ruadkow. (1974). Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83–92.
33. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295.
34. Gronthos S, J Brahim, W Li, LW Fisher, N Cherman, A Boyde, P DenBesten, PG Robey and S Shi. (2002). Stem cell properties of human dental pulp stem cells. J Dent Res 81:531–535.
35. Chong P, L Selvaratnam, AA Abbas and T Kamarul. (2012). Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res 30:634–642.
36. Aure MH, S Arany and C Ovitt. (2015). Salivary glands: stem cells, self-duplication, or both? J Dent Res 94:1502–1507.
37. Nombela-Arrieta C, J Ritz and LE Silberstein. (2011). The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 12:126–131.
38. Sellheyer K and D Krahl. (2010). Skin mesenchymal stem cells: prospects for clinical dermatology. J Am Acad Dermatol 63:859–865.
39. Wang S, X Qu and RC Zhao. (2012). Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:1–9.
40. Troyer DL and ML Weiss. (2008). Concise review: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591–599.
41. Rogers I and RF Casper. (2004). Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol 18:893–908.
42. Liu Z, Y Zhuge and OC Velazquez. (2009). Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106:984–991.
43. Orbay H, M Tobita and H Mizuno. (2012). Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int 2012:1–9.
44. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating. (2005). Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7:393–395.
45. Mafi P, S Hindocha, R Mafi, M Griffin and WS Khan. (2011). Suppl 2. Adult mesenchymal stem cells and cell surface characterization: a systematic review of the literature. Open Orthop J 5:253–260.
46. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147.
47. Kolf CM, E Cho and RS Tuan. (2007). Mesenchymal stromal cells: biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:1–10.
48. Bernardo ME and WE Fibbe. (2013). Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13:392–402.
49. Matuskova M, E Durinikova, C Altaner and L Kucerova. (2018). Genetically engineered mesenchymal stromal cells in cancer gene therapy. Bratisl Lek Listy 119:221–223.
50. Heubach JF, EM Graf, J Leutheuser, M Bock, B Balana, I Zahanich, T Christ, S Boxberger, E Wettwer and U Ravens. (2004). Electrophysiological properties of human mesenchymal stem cells. J Physiol 554:659–672.
51. Chu M-S, C-F Chang, C-C Yang, Y-C Bau, LL-T Ho and S-C Hung. (2006). Signalling pathway in the induction of neurite outgrowth in human mesenchymal stem cells. Cell Signal 18:519–530.
52. Ge C, WP Cawthorn, Y Li, G Zhao, OA MacDougald and RT Franceschi. (2016). Reciprocal control of osteogenic and adipogenic differentiation by ERK/MAP kinase phosphorylation of Runx2 and PPARγ transcription factors. J Cell Physiol 231:587–596.
53. Ge C, G Xiao, DI Jiang and RT Franceschi. (2007). Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 176:709–718.
54. Dalby MJ, AJ García and M Salmeron-Sanchez. (2018). Receptor control in mesenchymal stem cell engineering. Nat Rev Mater 3:1–14.
55. Danielyan L, R Schäfer, A Schulz, T Ladewig, A Lourhmati, M Buadze, AL Schmitt, S Verleysdonk, D Kabisch, et al. (2009). Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin. Cell Death Differ 16:1599–1614.
56. Zhu X and L Birnbaumer. (1996). G protein subunits and the stimulation of phospholipase C by Gs- and Gi-coupled receptors: lack of receptor selectivity of Galpha (16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein. Proc Natl Acad Sci U S A 93:2827–2831.
57. Yegani AA, E Maytalman, I Kozanoglu, MY Terzi and F Aksu. (2020). Biological behaviors of muscarinic receptors in mesenchymal stem cells derived from human placenta and bone marrow. Iran J Basic Med Sci 23:124–132.
58. Mona M, R Miller, H Li, YJ Park, R Zaman, LJ Yang and S Cha. (2019). MIST1, an inductive signal for salivary amylase in mesenchymal stem cells. Int J Mol Sci 20:767.
59. Tang JM, J Yuan, Q Li, JN Wang, X Kong, F Zheng, L Zhang, L Chen, LY Guo, et al. (2012). Acetylcholine induces mesenchymal stem cell migration via Ca 2+/PKC/ERK1/2 signal pathway. J Cell Biochem 113:2704–2713.
60. Chang W, S Lim, B-W Song, CY Lee, M-S Park, Y-A Chung, C Yoon, S-Y Lee, O Ham, et al. (2012). Phorbol myristate acetate differentiates human adipose-derived mesenchymal stem cells into functional cardiogenic cells. Biochem Biophys Res Commun 424:740–746.
61. Nery AA, RL Pereira, V Bassaneze, IC Nascimento, LS Sherman, P Rameshwar, C Lameu and H Ulrich. (2019). Combination of chemical and neurotrophin stimulation modulates neurotransmitter receptor expression and activity in transdifferentiating human adipose stromal cells. Stem Cell Rev Rep 15:851–863.
62. Ferreira JN, R Hasan, G Urkasemsin, KK Ng, C Adine, S Muthumariappan and GR Souza. (2019). A magnetic three-dimensional levitated primary cell culture system for the development of secretory salivary gland-like organoids. J Tissue Eng Regen Med 13:495–508.
63. Urkasemsin G, P Castillo, S Rungarunlert, N Klincumhom and JN Ferreira. (2019). Strategies for developing functional secretory epithelia from porcine salivary gland explant outgrowth culture models. Biomolecules 9:657.
64. Zablotni A, O Dakischew, K Trinkaus, S Hartmann, G Szalay, C Heiss and KS Lips. (2015). Regulation of acetylcholine receptors during differentiation of bone mesenchymal stem cells harvested from human reaming debris. Int Immunopharmacol 29:119–126.
65. Kotova PD, EN Kochkina, OO Lyamin, OA Rogachevskaja, NP Korolenko, DS Ivashin, MF Bystrova, NI Enukashvily and SS Kolesnikov. (2020). Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner. Eur J Pharmacol 880:173182.
66. Schraufstatter IU, RG DiScipio and SK Khaldoyanidi. (2010). Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. J Stem Cells 4:203.
67. Chan AHP and NF Huang. (2020). Effects of nicotine on the translation of stem cell therapy. Regen Med 15:1679–1688.
68. Xiao H, Y Wen, Z Pan, Y Shangguan, J Magdalou, H Wang and L Chen. (2019). Nicotine exposure during pregnancy programs osteopenia in male offspring rats via α4β2-nAChR–p300-ACE pathway. FASEB J 33:12972–12982.
69. Tie K, M Wu, Y Deng, Y Wen, X Dan, L Chen and H Wang. (2018). Histone hypo-acetylation of Sox9 mediates nicotine-induced weak cartilage repair by suppressing BMSC chondrogenic differentiation. Stem Cell Res Ther 9:98.
70. Pernarella M, R Piovesana, C Matera, A Faroni, M Fiore, L Dini, AJ Reid, C Dallanoce and AM Tata. (2020). Effects mediated by the alpha 7 nicotinic acetylcholine receptor on cell proliferation and migration in rat adipose-derived stem cells. Eur J Histochem 64:3159.
71. Kim SY, KL Kang, J-C Lee and JS Heo. (2012). Nicotinic acetylcholine receptor α7 and β4 subunits contribute nicotine-induced apoptosis in periodontal ligament stem cells. Mol Cells 33:343–350.
72. Zhou Z, B Li, Z Dong, F Liu, Y Zhang, Y Yu, F Shang, L Wu, X Wang and Y Jin. (2013). Nicotine deteriorates the osteogenic differentiation of periodontal ligament stem cells through alpha 7 nicotinic acetylcholine receptor regulating wnt pathway. PLoS One 8:e83102.
73. Spieker J, A Ackermann, A Salfelder, A Vogel-Höpker and PG Layer. (2016). Acetylcholinesterase regulates skeletal in ovo development of chicken limbs by ACh-dependent and -independent mechanisms. PLoS One 11:e0161675.
74. Spieker J, T Mudersbach, A Vogel-Höpker and PG Layer. (2017). Endochondral ossification is accelerated in cholinesterase-deficient mice and in avian mesenchymal micromass cultures. PLoS One 12:e0170252.
75. Thangaraj G, V Manakov, A Cucu, C Fournier and PG Layer. (2016). Inflammatory effects of TNFα are counteracted by X-ray irradiation and AChE inhibition in mouse micromass cultures. Chem Biol Interact 259:313–318.
76. Liu N, S Shi, M Deng, L Tang, G Zhang, N Liu, B Ding, W Liu, Y Liu and H Shi. (2011). High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway. J Bone Miner Res 26:2082–2095.
77. Yang X, Y Qi, L Avercenc-Leger, JB Vincourt, S Hupont, C Huselstein, H Wang, L Chen and J Magdalou. (2017). Effect of nicotine on the proliferation and chondrogenic differentiation of the human Wharton's jelly mesenchymal stem cells. Biomed Mater Eng 28:S217–S228.
78. Lykhmus O, O Kalashnyk, L Koval, L Voytenko, K Uspenska, S Komisarenko, O Deryabina, N Shuvalova, V Kordium, et al. (2019). Mesenchymal stem cells or interleukin-6 improve episodic memory of mice lacking alpha 7 nicotinic acetylcholine receptors. Neuroscience 413:31–44.
79. Michailovici I, HA Harrington, HH Azogui, Y Yahalom-Ronen, A Plotnikov, S Ching, MPH Stumpf, OD Klein, R Seger and E Tzahor. (2014). Nuclear to cytoplasmic shuttling of ERK promotes differentiation of muscle stem/progenitor cells. Development 141:2611–2620.
80. Kruse AC, BK Kobilka, D Gautam, PM Sexton, A Christopoulos and J Wess. (2014). Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat Rev Drug Discov 13:549–560.
81. Cheng H, J-M Feng, ML Figueiredo, H Zhang, PL Nelson, V Marigo and A Beck. (2010). Transient receptor potential melastatin type 7 channel is critical for the survival of bone marrow derived mesenchymal stem cells. Stem Cells Dev 19:1393–1403.
82. Mousawi F, H Peng, J Li, S Ponnambalam, S Roger, H Zhao, X Yang and L-H Jiang. (2020). Chemical activation of the Piezo1 channel drives mesenchymal stem cell migration via inducing ATP release and activation of P2 receptor purinergic signalling. Stem Cells 38:410–421.
83. Tsimbouri PM, PG Childs, GD Pemberton, J Yang, V Jayawarna, W Orapiriyakul, K Burgess, C Gonzalez-Garcia, G Blackburn and D Thomas. (2017). Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactor. Nat Biomed Eng 1:758–770.
84. Hong F, S Wu, C Zhang, L Li, J Chen, Y Fu and J Wang. (2020). TRPM7 upregulate the activity of SMAD1 through PLC signaling way to promote osteogenesis of hBMSCs. Biomed Res Int 2020:9458983.
85. Verma S, A Kumar, T Tripathi and A Kumar. (2018). Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy. J Pharm Pharmacol 70:985–993.
86. Decker MW, MD Meyer and JP Sullivan. (2001). The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control. Expert Opin Investig Drugs 10:1819–1830.

Information & Authors

Information

Published In

cover image Stem Cells and Development
Stem Cells and Development
Volume 32Issue Number 3-4February 2023
Pages: 47 - 59
PubMed: 36355611

History

Published online: 6 February 2023
Published in print: February 2023
Published ahead of print: 24 January 2023
Published ahead of production: 10 November 2022
Accepted: 8 November 2022
Received: 25 August 2022

Permissions

Request permissions for this article.

Topics

    Authors

    Affiliations

    School of Medicine Dentistry and Nursing and University of Glasgow, Glasgow, United Kingdom.
    School of Medicine Dentistry and Nursing and University of Glasgow, Glasgow, United Kingdom.
    School of Medicine Dentistry and Nursing and University of Glasgow, Glasgow, United Kingdom.
    Matthew J. Dalby
    School of Molecular Biosciences, University of Glasgow, Glasgow, United Kingdom.
    School of Medicine Dentistry and Nursing and University of Glasgow, Glasgow, United Kingdom.
    Faculty of Medical Sciences, School of Dental Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.

    Notes

    *
    Considered joint senior authors.
    Address correspondence to: Dr. Saeed Alqahtani, School of Medicine Dentistry and Nursing, University of Glasgow, 378 Sauchiehall Street, Glasgow G2 3JZ, United Kingdom [email protected]

    Author Disclosure Statement

    The authors have no relevant financial or nonfinancial interests to disclose.

    Funding Information

    M.C.B. was funded by GlaxoSmithKline Consumer Health care and the BBSRC Industrial GlaxoSmithKline CASE PhD studentship (BB/V509541/1).

    Metrics & Citations

    Metrics

    Citations

    Export citation

    Select the format you want to export the citations of this publication.

    View Options

    Get Access

    Access content

    To read the fulltext, please use one of the options below to sign in or purchase access.

    Society Access

    If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

    Restore your content access

    Enter your email address to restore your content access:

    Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

    View options

    PDF/EPUB

    View PDF/ePub

    Full Text

    View Full Text

    Media

    Figures

    Other

    Tables

    Share

    Share

    Copy the content Link

    Share on social media

    Back to Top